Cagrilintide

Overview

Aurex Cagrilintide is a premium, long-acting amylin analog formulated for advanced metabolic research. As a potent dual-agonist peptide, this 10mg concentration provides researchers with a significant quantity to study complex mechanisms of appetite regulation, glucose homeostasis, and long-term weight management.

Key Features & Benefits

• Dual-Receptor Agonist: Engineered to activate both amylin and calcitonin receptors, providing a robust tool for studying synergistic metabolic pathways.
• Ideal for Extended Studies: The 10mg quantity supports longer-duration research protocols on satiety signaling and energy balance.
• Enhanced Pharmacokinetic Profile: Features albumin-binding technology for a significantly extended plasma half-life, ideal for sustained research models.
• Ultra-Pure Research Standard: Each vial contains 10mg of Cagrilintide synthesized to ≥ 99% purity (HPLC verified), ensuring exceptional batch-to-batch consistency.

Primary Research Applications

• Long-term investigation of compound effects on food intake, satiety, and adiposity.
• Study of glucose-dependent insulin secretion and insulin sensitivity pathways.
• Research into the central nervous system’s role in appetite regulation and energy expenditure.
• Comparative efficacy studies of single versus dual-hormone receptor activation.

Product Specifications

• Unit Size: 10mg (vial format)
• Compound: Cagrilintide (AM833)
• Purity: ≥ 99% (HPLC verified)
• Quantity: 10mg per sterile lyophilized vial
• Form: Lyophilized (freeze-dried) powder
• Molecular Weight: ~4.1 kDa
• Storage: For long-term stability, store at or below -20°C. Keep the vial tightly sealed and protected from moisture.

Important Notice

This product is for in-vitro and laboratory research use only. It is not for human or veterinary consumption, diagnosis, or treatment. Cagrilintide is a potent peptide and must be handled by trained professionals using appropriate laboratory safety protocols.